HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$6.75
Day range
$6.61 - $7.05
Year range
$1.78 - $8.45
Market cap
301.42M USD
Avg Volume
857.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.59M | 196.65% |
Net income | -42.08M | -221.45% |
Net profit margin | — | — |
Earnings per share | -0.97 | -44.78% |
EBITDA | -44.37M | -32.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 211.68M | -38.86% |
Total assets | 226.51M | -37.62% |
Total liabilities | 42.13M | 42.30% |
Total equity | 184.38M | — |
Shares outstanding | 43.25M | — |
Price to book | 1.58 | — |
Return on assets | -45.58% | — |
Return on capital | -52.71% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -42.08M | -221.45% |
Cash from operations | -31.95M | -32.16% |
Cash from investing | 29.17M | 142.94% |
Cash from financing | -649.00K | -14.06% |
Net change in cash | -3.43M | 96.30% |
Free cash flow | -16.08M | -3.29% |
About
Founded
2018
Headquarters
Website
Employees
129
